4126.0 From Harm Reduction to Overdose to EBP: A Broad Approach to Treatment

Tuesday, October 28, 2008: 12:30 PM

Board 1
Board 2
Role of pharmacies in buprenorphine treatment
Danae Nicole DiRocco, MPH, Helena Hansen, MD, PhD and Marc Galanter, MD
Board 3
Financial Barriers to Implementation of Evidence-Based Practices for Alcohol and Drug Treatment
Holly Fussell, PhD, Traci Rieckmann, PhD, Anne Kovas, MPH and Nicole Stettler, BS
Board 4
Impact of local changes in clinic and study practices on retention of opiate-dependent participants in a multi-site clinical trial
Katharina Wiest, PhD, Dennis McCarty, PhD, Tim Hartnett, MSW, MHA, Lynn Kunkel, MS, CCRP, Diane Lape, BA, Diane Gasperin, BA, Albert Hasson, MSW and Christie Thomas, MPH
Board 5
Is state Medicaid plan coverage for ancillary/transitional assistance services related to services offered by outpatient programs accepting Medicaid?
Jamie F. Chriqui, PhD, MHS, Yvonne Terry-McElrath, MSA, Duane C. McBride, PhD and Shelby S. Eidson, JD
Board 6
Survey analyses for implementing an electronic information system to enhance practice at an opioid treatment program
Melissa Chu, MS, Steven Kritz, MD, Charles Madray, RPA-C, MBA, Carlota John-Hull, MD, Ben Louie, BA, Adashima Muhammad, MPH and Lawrence S. Brown, MD, MPH, FASAM
Board 7
Diversifying the Settings of Opioid Overdose Prevention Trainings: Lessons for Implementation
Caroline Rath, PA-C, MS, Sharon Stancliff, MD and Jagadisa-devasri Dacus, LMSW

See individual abstracts for presenting author's disclosure statement and author's information.

Organized by: Alcohol, Tobacco, and Other Drugs